|
|
|
|
|
|
|
||
Address correspondence to Shai Silberberg, Department of Life Sciences Ben-Gurion, University of the Negev, P.O. Box 653, Beer-Sheva 84105, Israel. Fax: (972) 8-6461-710; email: Silber{at}bgumail.bgu.ac.il
Ivermectin (IVM), a widely used antiparasitic agent in human and veterinary medicine, was recently shown to augment macroscopic currents through rat P2X4 receptor channels (Khakh, B.S., W.R. Proctor, T.V. Dunwiddie, C. Labarca, and H.A. Lester. 1999. J. Neurosci. 19:7289–7299.). In the present study, the effects of IVM on the human P2X4 (hP2X4) receptor channel stably transfected in HEK293 cells were investigated by recording membrane currents using the patch clamp technique. In whole-cell recordings, IVM (
10 µM) applied from outside the cell (but not from inside) increased the maximum current activated by ATP, and slowed the rate of current deactivation. These two phenomena likely result from the binding of IVM to separate sites. A higher affinity site (EC50 0.25 µM) increased the maximal current activated by saturating concentrations of ATP without significantly changing the rate of current deactivation or the EC50 and Hill slope of the ATP concentration-response relationship. A lower affinity site (EC50 2 µM) slowed the rate of current deactivation, and increased the apparent affinity for ATP. In cell-attached patch recordings, P2X4 receptor channels exhibited complex kinetics, with multiple components in both the open and shut distributions. IVM (0.3 µM) increased the number of openings per burst, without significantly changing the mean open or mean shut time within a burst. At higher concentrations (1.5 µM) of IVM, two additional open time components of long duration were observed that gave rise to long-lasting bursts of channel activity. Together, the results suggest that the binding of IVM to the higher affinity site increases current amplitude by reducing channel desensitization, whereas the binding of IVM to the lower affinity site slows the deactivation of the current predominantly by stabilizing the open conformation of the channel.
Key Words: ion channel gating • allosteric regulation • purinergic receptors • ATP • patch clamp techniques
CiteULike 
Complore 
Connotea 
Del.icio.us 
Digg 
Reddit 
Technorati What's this?
This article has been cited by other articles:
|
|
 |
|
  U. Lalo, Y. Pankratov, S. P. Wichert, M. J. Rossner, R. A. North, F. Kirchhoff, and A. Verkhratsky P2X1 and P2X5 Subunits Form the Functional P2X Receptor in Mouse Cortical Astrocytes J. Neurosci., May 21, 2008; 28(21): 5473 - 5480. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Guo, M. Masin, O. S. Qureshi, and R. D. Murrell-Lagnado Evidence for Functional P2X4/P2X7 Heteromeric Receptors Mol. Pharmacol., December 1, 2007; 72(6): 1447 - 1456. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 O. S. Qureshi, A. Paramasivam, J. C. H. Yu, and R. D. Murrell-Lagnado Regulation of P2X4 receptors by lysosomal targeting, glycan protection and exocytosis J. Cell Sci., November 1, 2007; 120(21): 3838 - 3849. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y. Zhang, D. Sanchez, J. Gorelik, D. Klenerman, M. Lab, C. Edwards, and Y. Korchev Basolateral P2X4-like receptors regulate the extracellular ATP-stimulated epithelial Na+ channel activity in renal epithelia Am J Physiol Renal Physiol, June 1, 2007; 292(6): F1734 - F1740. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. A. Sim, S. Chaumont, J. Jo, L. Ulmann, M. T. Young, K. Cho, G. Buell, R. A. North, and F. Rassendren Altered Hippocampal Synaptic Potentiation in P2X4 Knock-Out Mice. J. Neurosci., August 30, 2006; 26(35): 9006 - 9009. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. J. Fountain and R. A. North A C-terminal Lysine That Controls Human P2X4 Receptor Desensitization J. Biol. Chem., June 2, 2006; 281(22): 15044 - 15049. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. Zemkova, A. Balik, Y. Jiang, K. Kretschmannova, and S. S. Stojilkovic Roles of Purinergic P2X Receptors as Pacemaking Channels and Modulators of Calcium-Mobilizing Pathway in Pituitary Gonadotrophs Mol. Endocrinol., June 1, 2006; 20(6): 1423 - 1436. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J.-B. Shen, A. J. Pappano, and B. T. Liang Extracellular ATP-stimulated current in wild-type and P2X4 receptor transgenic mouse ventricular myocytes: implications for a cardiac physiologic role of P2X4 receptors FASEB J, February 1, 2006; 20(2): 277 - 284. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. Toulme, F. Soto, M. Garret, and E. Boue-Grabot Functional Properties of Internalization-Deficient P2X4 Receptors Reveal a Novel Mechanism of Ligand-Gated Channel Facilitation by Ivermectin Mol. Pharmacol., February 1, 2006; 69(2): 576 - 587. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. D. Silberberg, T.-H. Chang, and K. J. Swartz Secondary Structure and Gating Rearrangements of Transmembrane Segments in Rat P2X4 Receptor Channels J. Gen. Physiol., March 28, 2005; 125(4): 347 - 359. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Priel, A. Kolleker, G. Ayalon, M. Gillor, P. Osten, and Y. Stern-Bach Stargazin Reduces Desensitization and Slows Deactivation of the AMPA-Type Glutamate Receptors J. Neurosci., March 9, 2005; 25(10): 2682 - 2686. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Kelvin. C. Agboh, T. E. Webb, R. J. Evans, and S. J. Ennion Functional Characterization of a P2X Receptor from Schistosoma mansoni J. Biol. Chem., October 1, 2004; 279(40): 41650 - 41657. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. A. Brown, J. I. E. Bruce, S. V. Straub, and D. I. Yule cAMP Potentiates ATP-evoked Calcium Signaling in Human Parotid Acinar Cells J. Biol. Chem., September 17, 2004; 279(38): 39485 - 39494. [Abstract] [Full Text] [PDF]
|
|
|
|
